An official website of the United States government
Table 2.1. Number and rates* of reported cases† of acute hepatitis B virus infection, by state or jurisdiction — United States, 2015–2019
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported cases that met the classification criteria for a confirmed case. For the case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-b-acute/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
* Rates per 100,000 population.
† Reported cases that met the classification criteria for a confirmed case. For the case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-b-acute/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
The capacity for notifying CDC of acute hepatitis B virus infection cases varies considerably on the basis of laws, resources, and infrastructure for conducting viral hepatitis surveillance in each jurisdiction. The national rate of acute hepatitis B was 1.0 reported cases per 100,000 population during 2019. Maine had the highest reported rate of acute hepatitis B during 2019 (4.3 cases per 100,000 population). Five states with the highest number of reported acute cases (Florida, Ohio, Tennessee, Kentucky, and North Carolina) accounted for approximately half of the national burden of acute hepatitis B cases reported during 2019.
Hepatitis B Figures and Tables
- Figure 2.1. Number of reported acute hepatitis B virus cases and estimated infections — United States, 2012–2019
- Figure 2.2. Rates of reported acute hepatitis B virus infection, by state — United States, 2018–2019
- Figure 2.3. Rates of reported acute hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Figure 2.4. Rates of reported acute hepatitis B virus infection, by age group — United States, 2004–2019
- Figure 2.5. Rates of reported acute hepatitis B virus infection, by sex — United States, 2004–2019
- Figure 2.6. Rates of reported acute hepatitis B virus infections, by race/ethnicity — United States, 2004–2019
- Figure 2.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2019
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 2.1. Number and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2015–2019
- Table 2.2. Number and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States 2015–2019
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2019
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.5. Number and rates of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.6. Number and rates of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2019
- Table 2.7. Number and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 2.8. Number and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019